Unfortunately, two of the most common drug therapies for OSCC, cisplatin chemotherapy and checkpoint inhibitor anti-PD1 (programmed cell death protein 1) immunotherapy, also exacerbate cancer pain and opioid dependence [22,23]. This evidence concerns the gene PDCD1 and opiate dependence.